Statistics

Total Visits

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice27

Select a period of time:

Number of views in the range

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice5

Views

Views
June 20250
July 20250
August 20250
September 20251
October 20252
November 20251
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Argentina1
Costa Rica1
 

Top cities views

Views
Spokane2
Dallas1
Mendoza1
San José1